A genome-wide methylation approach identifies a new hypermethylated gene panel in ulcerative colitis

International Journal of Molecular Sciences

Volumn 17, Issue 8, 2016, Pages

  Kang, Keunsoo ^a   Bae, Jin Han ^b   Han, Kyudong ^a   Kim, Eun Soo ^c   Kim, Tae Oh ^d   Yi, Joo Mi ^b  

^a Dankook University   (South Korea)

^b Dongnam Institute of Radiological Medical Sciences (DIRAMS)   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Inje University College of Medicine   (South Korea)

Author keywords

Biomarker; DNA methylation profile; Promoter hypermethylation; Ulcerative colitis

Indexed keywords

GENOMIC DNA; BIOLOGICAL MARKER;

ADULT; ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; DNA TRANSCRIPTION; FEMALE; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; MOLECULAR PATHOLOGY; POLYMERASE CHAIN REACTION; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; ULCERATIVE COLITIS; GENETIC EPIGENESIS; GENETICS; IN VITRO STUDY;

ADULT; BIOMARKERS; COLITIS, ULCERATIVE; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; IN VITRO TECHNIQUES; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 84981517783     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17081291     Document Type: Article

References (41)

1. Kaser, A.; Zeissig, S.; Blumberg, R.S. Inflammatory bowel disease. Annu. Rev. Immunol. 2010, 28, 573-621
2. Fiocchi, C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998, 115, 182-205
3. Franke, A.; Balschun, T.; Karlsen, T.H.; Hedderich, J.; May, S.; Lu, T.; Schuldt, D.; Nikolaus, S.; Rosenstiel, P.; Krawczak, M.; et al. Replication of signals from recent studies of crohn’s disease identifies previously unknown disease loci for ulcerative colitis. Nat. Genet. 2008, 40, 713-715
4. Franke, A.; McGovern, D.P.B.; Barrett, J.C.; Wang, K.; Radford-Smith, G.L.; Ahmad, T.; Lees, C.W.; Balschun, T.; Lee, J.; Roberts, R.; et al. Genome-wide meta-analysis increases to 71 the number of confirmed crohn’s disease susceptibility loci. Nat. Genet. 2010, 42, 1118-1125
5. Anderson, C.A.; Boucher, G.; Lees, C.W.; Franke, A.; D’Amato, M.; Taylor, K.D.; Lee, J.C.; Goyette, P.; Imielinski, M.; Latiano, A.; et al. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat. Genet. 2011, 43, 246-252
6. Jostins, L.; Ripke, S.; Weersma, R.K.; Duerr, R.H.; McGovern, D.P.; Hui, K.Y.; Lee, J.C.; Philip Schumm, L.; Sharma, Y.; Anderson, C.A.; et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012, 491, 119-124
7. Herman, J.G.; Baylin, S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 2003, 349, 2042-2054
8. Bibikova, M. High density DNA methylation array with single cpg site resolution. Genomics 2011, 98, 288-295
9. Jones, P.A.; Baylin, S.B. The epigenomics of cancer. Cell 2007, 128, 683-692
10. Robertson, K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6, 597-610
11. Karatzas, P.S.; Gazouli, M.; Safioleas, M.; Mantzaris, G.J. DNA methylation changes in inflammatory bowel disease. Ann. Gastroenterol.: Quart. Pub. Hellenic Soc. Gastroenterol. 2014, 27, 125-132.
12. Kim, J.-G.; Park, M.-T.; Heo, K.; Yang, K.-M.; Yi, J.M. Epigenetics meets radiation biology as a new approach in cancer treatment. Int. J. Mol. Sci. 2013, 14, 15059-15073
13. Portela, A.; Esteller, M. Epigenetic modifications and human disease. Nat. Biotechnol. 2010, 28, 1057-1068
14. Kim, T.-O.; Park, J.; Kang, M.J.; Lee, S.H.; Jee, S.R.; Rye, D.Y.; Yang, K.; Yi, J.M. DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int. J. Mol. Sci. 2013, 31, 1255-1261.
15. Yi, J.M.; Dhir, M.; van Neste, L.; Downing, S.R.; Jeschke, J.; Glöckner, S.C.; de Freitas Calmon, M.; Hooker, C.M.; Funes, J.M.; Boshoff, C.; et al. Genomic and epigenomic integration identifies a prognostic signature in colon cancer. Clin. Cancer Res. 2011, 17, 1535-1545
16. Khor, B.; Gardet, A.; Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011, 474, 307-317
17. Supek, F.; Bošnjak, M.; Škunca, N.; Šmuc, T. Revigo summarizes and visualizes long lists of gene ontology terms. PLoS ONE 2011, 6, e21800
18. Petronis, A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010, 465, 721-727
19. Stoll, M.; Corneliussen, B.; Costello, C.M.; Waetzig, G.H.; Mellgard, B.; Koch, W.A.; Rosenstiel, P.; Albrecht, M.; Croucher, P.J.P.; Seegert, D.; et al. Genetic variation in dlg5 is associated with inflammatory bowel disease. Nat. Genet. 2004, 36, 476-480
20. Van Overveld, P.G.M.; Lemmers, R.J.F.L.; Sandkuijl, L.A.; Enthoven, L.; Winokur, S.T.; Bakels, F.; Padberg, G.W.; van Ommen, G.-J.B.; Frants, R.R.; van der Maarel, S.M. Hypomethylation of d4z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 2003, 35, 315-317
21. Ventham, N.T.; Kennedy, N.A.; Nimmo, E.R.; Satsangi, J. Beyond gene discovery in inflammatory bowel disease: The emerging role of epigenetics. Gastroenterology 2013, 145, 293-308
22. Hartnett, L.; Egan, L.J. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis 2012, 33, 723-731
23. Hsieh, C.J.; Klump, B.; Holzmann, K.; Borchard, F.; Gregor, M.; Porschen, R. Hypermethylation of the p16ink4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res. 1998, 58, 3942-3945
24. Wang, F.; Arisawa, T.; Tahara, T.; Takahama, K.; Watanabe, M.; Hirata, I.; Nakano, H. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology 2008, 55, 62-65
25. Gould, N.J.D.; Davidson, K.L.M.; Nwokolo, C.U.; Arasaradnam, R.P. A systematic review of the role of DNA methylation on inflammatory genes in ulcerative colitis. Epigenomics 2016, 8, 667-684
26. Esteller, M.; Fraga, M.F.; Paz, M.F.; Campo, E.; Colomer, D.; Novo, F.J.; Calasanz, M.J.; Galm, O.; Guo, M.; Benitez, J.; et al. Cancer epigenetics and methylation. Science 2002, 297, 1807-1808
27. Laird, P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 2003, 3, 253-266
28. Karatzas, P.S.; Mantzaris, G.J.; Safioleas, M.; Gazouli, M. DNA methylation profile of genes involved in inflammation and autoimmunity in inflammatory bowel disease. Medicine 2014, 93, e309
29. Li Yim, A.Y.F.; Duijvis, N.W.; Zhao, J.; de Jonge, W.J.; D’Haens, G.R.A.M.; Mannens, M.M.A.M.; Mul, A.N.P.M.; de Velde, A.A.; Henneman, P. Peripheral blood methylation profiling of female crohn’s disease patients. Clin. Epigenet. 2016, 8, 1-13
30. Johnson, D.H.; Taylor, W.R.; Aboelsoud, M.M.; Foote, P.H.; Yab, T.C.; Cao, X.; Smyrk, T.C.; Loftus, E.V., Jr.; Mahoney, D.W.; Ahlquist, D.A.; et al. DNA methylation and mutation of small colonic neoplasms in ulcerative colitis and crohn’s colitis: Implications for surveillance. Inflamm. Bowel Dis. 2016, 22
31. Papadia, C.; Louwagie, J.; del Rio, P.; Grooteclaes, M.; Coruzzi, A.; Montana, C.; Novelli, M.; Bordi, C.; de’ Angelis, G.L.; Bassett, P.; et al. Foxe1 and syne1 genes hypermethylation panel as promising biomarker in colitis-associated colorectal neoplasia. Inflamm. Bowel Dis. 2014, 20, 271-277
32. DeVos, T.; Tetzner, R.; Model, F.; Weiss, G.; Schuster, M.; Distler, J.; Steiger, K.V.; Grützmann, R.; Pilarsky, C.; Habermann, J.K.; et al. Circulating methylated sept9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 2009, 55, 1337-1346
33. Glockner, S.C.; Dhir, M.; Yi, J.M.; McGarvey, K.E.; van Neste, L.; Louwagie, J.; Chan, T.A.; Kleeberger, W.; de Bruïne, A.P.; Smits, K.M.; et al. Methylation of tfpi2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer. Cancer Res. 2009, 69, 4691-4699
34. Li, M.; Chen, W.-D.; Papadopoulos, N.; Goodman, S.N.; Bjerregaard, N.C.; Laurberg, S.; Levin, B.; Juhl, H.; Arber, N.; Moinova, H.; et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat. Biotechnol. 2009, 27, 858-863
35. Azarschab, P.; Porschen, R.; Gregor, M.; Blin, N.; Holzmann, K. Epigenetic control of the e-cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis. Genes Chromosome Cancer 2002, 35, 121-126
36. Saito, S.; Kato, J.; Hiraoka, S.; Horii, J.; Suzuki, H.; Higashi, R.; Kaji, E.; Kondo, Y.; Yamamoto, K. DNA methylation of colon mucosa in ulcerative colitis patients: Correlation with inflammatory status. Inflamm. Bowel Dis. 2011, 17, 1955-1965
37. Du, P.; Kibbe, W.A.; Lin, S.M. Lumi: A pipeline for processing illumina microarray. Bioinformatics 2008, 24, 1547-1548
38. Du, P.; Davis, S.; Bilke, T.; Triche, J.T.; Bootawalla, M. Methylumi: Handle illumina methylation data. Available online: https://www.scienceopen.com/document?vid=4d66aeae-d817-400f-a84c-0b0df0066f3e (accessed on 30 June 2015).
39. Teschendorff, A.E.; Marabita, F.; Lechner, M.; Bartlett, T.; Tegner, J.; Gomez-Cabrero, D.; Beck, S. A beta-mixture quantile normalization method for correcting probe design bias in illumina infinium 450 k DNA methylation data. Bioinformatics 2013, 29, 189-196
40. Kim, J.-G.; Kim, T.-O.; Bae, J.-H.; Shim, J.-W.; Kang, M.J.; Yang, K.; Ting, A.H.; Yi, J.M. Epigenetically regulated mir941 and mir1247 target gastric cancer cell growth and migration. Epigenetics 2014, 9, 1018-1030
41. Warde-Farley, D.; Donaldson, S.L.; Comes, O.; Zuberi, K.; Badrawi, R.; Chao, P.; Franz, M.; Grouios, C.; Kazi, F.; Lopes, C.T.; et al. The genemania prediction server: Biological network integration for gene prioritization and predicting gene function. Nucleic Acid. Res. 2010, 38, W214-W220